Cargando…
What to expect from different drugs used in the treatment of COVID-19: A study on applications and in vivo and in vitro results
The end of 2019 was marked by the emergence of a new type of coronavirus (SARS-CoV-2), which has killed more than 240,000 people around the world so far. Several clinical studies are being performed to test possible drugs in response to the COVID-19 outbreak; however, there is still no treatment tha...
Autores principales: | Marcolino, Vanessa Aparecida, Pimentel, Tatiana Colombo, Barão, Carlos Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414419/ https://www.ncbi.nlm.nih.gov/pubmed/32777212 http://dx.doi.org/10.1016/j.ejphar.2020.173467 |
Ejemplares similares
-
Effects of SARS Cov-2 epidemic on the obstetrical and gynecological emergency service accesses. What happened and what shall we expect now?()
por: Dell’Utri, Chiara, et al.
Publicado: (2020) -
In vivo and in vitro Pathogenesis and Virulence Factors of Candida albicans Strains Isolated from Cutaneous Candidiasis
por: Sadeghi, Golnar, et al.
Publicado: (2020) -
Box-Wilson Design for Optimization of in vitro Levan Production and Levan Application as Antioxidant and Antibacterial Agents
por: Hertadi, Rukman, et al.
Publicado: (2021) -
Nanoemulsions as novel nanocarrieres for drug delivery across the skin: In-vitro, in-vivo evaluation of miconazole nanoemulsions for treatment of Candidiasis albicans
por: Farooq, Umar, et al.
Publicado: (2021) -
Isobutanol production by combined in vivo and in vitro metabolic engineering
por: Gupta, Mamta, et al.
Publicado: (2022)